Hot Products
| Catalog No. | Information |
| CFN90512 | 10-Hydroxy-2-decenoic acid 10-Hydroxy-2-decenoic acid is a potential HDACI which inhibits the proliferation of FLS cells by PI3K-AKT pathway; it exerts an inhibitory effect on VEGF-induced angiogenesis, partly by inhibiting both cell proliferation and migration. 10-Hydroxy-2-decenoic acid activates AMPK, and insulin independently enhances glucose uptake following translocation of Glut4 to PM; it also can prevent UVA-induced damage and inhibit MMP-1 and MMP-3 expressions. |
| CFN99736 | 10-Hydroxycamptothecin 10-Hydroxycamptothecin is a cell-permeable powerful DNA topoisomerase I inhibitor. It has selective inhibitory effect on the phosphorylation of histone H1 and H3, but less effect on other histones.10-Hydroxycamptothecin anticancer, and antiangiogenic activities, it can prevent fibroblast proliferation and epidural scar adhesion after laminectomy in rats. |
| CFN94012 | 10-Hydroxycanthin-6-one 10-Hydroxycanthin-6-one has potential to be an antimicrobial agent. 10-Hydroxycanthin-6-one has in vitro antimalarial activity; it also has cytotoxic activity, it could be a plant anticancer agent. |
| CFN90157 | 10-Methoxycamptothecin 10-Methoxycamptothecin possesses high anti-cancer activity. |
| CFN97953 | 10-O-Caffeoyl-6-epiferetoside Reference standards. |
| CFN92300 | 10-Shogaol 10-Shogaol, as an antioxidant for human skin cell growth and a migration enhancer with potential to be a novel wound repair agent.8- and 10-Shogaol have similar metabolic profiles to [6]-shogaol and exhibit similar toxicity toward human colon cancer cells. |
| CFN97438 | 11(13)-Dehydroivaxillin 11(13)-Dehydroivaxillin possesses a promising antiplasmodial activity, which can be exploited in malaria therapy. |
| CFN97819 | 11,13-Dihydroivalin Standard reference |
| CFN89426 | 11-Anhydro-16-oxoalisol A Reference standards. |
| CFN95433 | 11beta,13-Dihydrolactucin 11beta,13-Dihydrolactucin has analgesic effect and anti-inflammatory potential . |
